Antibiotic Developments Insights
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process.
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research.
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance.
29 Nov 2021
AMR in Orthopedics – Benefits of topical treatment and latest advances
Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry.
7 Oct 2021
Improving our approach to fighting AMR
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR).
11 Aug 2021
The state of bioinformatics in the fight against AMR
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance.
27 Jan 2021
nobeastsofierce Shutterstock
Glox Therapeutics awarded grant to accelerate development of precision antibiotics
Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy).
25 Nov 2024
Sawyer0/Adobe Stock
Global study shows cefiderocol’s success in treating resistant infections
Shionogi & Co., Ltd. shared new data at IDWeek 2024 from the PROVE study, the largest global real-world evidence review of Fetroja/Fetcroja (cefiderocol).
17 Oct 2024
Shutterstock
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges.
8 Mar 2024
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Aragen
Q&A: Aragen shares 2026 predictions
European Pharmaceutical Manufacturer spoke to Ashu Tandon, COO, Aragen at CPHI Frankfurt about their 2026 predictions for the company.
8 Dec 2025
Shutterstock - DIA TV
Q&A: Syngene at CPHI Frankfurt
At CPHI Frankfurt, we sat down with Peter Bains, MD & CEO of Syngene International, to discuss the company’s recent investments in peptides and antibody–drug conjugates (ADCs) and the broader evolution of integrated development in biologics.
5 Dec 2025
Testo Saveris
Pinpoint accuracy: the importance of calibration in pharmaceutical measurement
Dr. Fábio A. S. Leite, subject matter expert for Pharma, Testo Saveris discusses how in the pharmaceutical sector, sensors are the frontline of medicine integrity, safeguarding sterility, maintaining quality and ultimately facilitating patient care.
4 Dec 2025
Bio-Rad Laboratories
Streamlining biopharmaceutical purification with continuous chromatography
Heidi Jones, market development manager, Chromatography, Bio-Rad Laboratories discusses streamlining biopharmaceutical purification with continuous chromatography.
3 Dec 2025
Building robust and reliable paths for biologics manufacturing
Ingenza looks at building robust and reliable paths for biologics manufacturing.
28 Nov 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
SpaceGuard Products
Integrating safety and automation
Ray Niemeyer, vice president of sales at SpaceGuard Products, discusses wire mesh guarding for robotic and automated facilities.
27 Nov 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00